Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis

Kilian Eyerich, Khusru Asadullah, Andreas Pinter, Peter Weisenseel, Kristian Reich, Carle Paul, Robert Sabat, Kerstin Wolk, Stefanie Eyerich, Felix Lauffer, Julianty Angsana, Friedemann J. H. Taut, Kristen Kohler, Yanqing Chen, Jocelyn Sendecki, Monica W. L. Leung, Sven Wegner, Yvonne Personke, Mario Gomez, Nenja Krüger, Sarah Tabori, Knut Schäkel

Open source

DOI: 10.1001/jamadermatol.2024.2463
Published: 2024-09-01
Container: JAMA Dermatology
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2024.2463,
  title = {Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis},
  author = {Kilian Eyerich and Khusru Asadullah and Andreas Pinter and Peter Weisenseel and Kristian Reich and Carle Paul and Robert Sabat and Kerstin Wolk and Stefanie Eyerich and Felix Lauffer and Julianty Angsana and Friedemann J. H. Taut and Kristen Kohler and Yanqing Chen and Jocelyn Sendecki and Monica W. L. Leung and Sven Wegner and Yvonne Personke and Mario Gomez and Nenja Krüger and Sarah Tabori and Knut Schäkel},
  year = {2024},
  journal = {JAMA Dermatology},
  doi = {10.1001/jamadermatol.2024.2463},
  url = {https://doi.org/10.1001/jamadermatol.2024.2463}
}

RIS

TY  - JOUR
TI  - Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis
AU  - Kilian Eyerich
AU  - Khusru Asadullah
AU  - Andreas Pinter
AU  - Peter Weisenseel
AU  - Kristian Reich
AU  - Carle Paul
AU  - Robert Sabat
AU  - Kerstin Wolk
AU  - Stefanie Eyerich
AU  - Felix Lauffer
AU  - Julianty Angsana
AU  - Friedemann J. H. Taut
AU  - Kristen Kohler
AU  - Yanqing Chen
AU  - Jocelyn Sendecki
AU  - Monica W. L. Leung
AU  - Sven Wegner
AU  - Yvonne Personke
AU  - Mario Gomez
AU  - Nenja Krüger
AU  - Sarah Tabori
AU  - Knut Schäkel
PY  - 2024
JO  - JAMA Dermatology
DO  - 10.1001/jamadermatol.2024.2463
UR  - https://doi.org/10.1001/jamadermatol.2024.2463
ER  -

APA

Eyerich, K., Asadullah, K., Pinter, A., Weisenseel, P., Reich, K., Paul, C., Sabat, R., Wolk, K., Eyerich, S., Lauffer, F., Angsana, J., Taut, F. J. H., Kohler, K., Chen, Y., Sendecki, J., Leung, M. W. L., Wegner, S., Personke, Y., Gomez, M., Krüger, N., Tabori, S., & Schäkel, K. (2024). Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.2463

Source records

crossref · retrieved 2026-09-26T00:48:35.356Z